J&J MedTech to work with NVIDIA for surgical AI
Betsy Goodfellow | March 19, 2024 | News story | Research and Development | Johnson & Johnson MedTech, NVIDIA, Pharmacy, surgery, surgical AI
Johnson & Johnson (J&J) MedTech has announced that it is working in collaboration with NVIDIA to accelerate and scale artificial intelligence (AI) for use in surgeries.
This partnership is intended to support ‘increased access to real-time analysis and global availability of AI algorithms for surgical decision-making, education and collaboration across the connected operating room (OR)’, according to the company’s press release.
The two companies are expected to collaborate for the acceleration of AI for J&J MedTech’s surgical technologies portfolio with NVIDIA’s AI healthcare platform.
Tim Schmid, executive vice president and worldwide chairman of J&J MedTech, commented: “Johnson & Johnson MedTech is advancing healthcare toward a future that’s more connected and personalised. This future will be increasingly enabled by digital technologies that deliver efficiency, inform decision-making and extend surgical training and education. Our deep heritage in healthcare and digital ecosystem in surgery and NVIDIA’s AI platforms hold enormous potential to create a more connected surgical experience.”
Shan Jegatheewaran, vice president and global head of digital at J&J MedTech, added: “One of the major challenges in scaling AI for surgery is the closed design of surgical technologies. Bringing advanced edge computing hardware and software to the OR enables scalability of innovation and new AI-powered solutions for clinical decision-making, education and training, and collaboration – with the ultimate goal of advancing patient care.”
Betsy Goodfellow
Related Content
Johnson & Johnson’s MedTech announce orthopaedics receives 501K clearance from FDA for spinal robotics and navigation platform
Today, the Orthopaedics branch of Johnson & Johnson MedTech, DePuy Synthes, has announced that their …
J&J’s to submit surgical robot to FDA in 2024
Johnson & Johnson MedTech have announced plans to submit the Ottava robotic surgical system to …
Personalised medicine in oncology: Where are we now?
The past decade has seen exponential growth in the field of oncology, with precision medicine …
